Related Experiment Videos
Easy and practical utilization of CONSAM for simulation, analysis, and optimization of complex dosing regimens
1Division of Bioequivalence, Center for Drug Evaluation and Research, Food and Drug Administration, Rockville, MD 20857.
Journal of Pharmaceutical Sciences
|April 1, 1991
Summary
A new dosing program, CONSAM, rapidly calculates complex drug regimens for up to 3 compartments. It allows for individual dosage optimization and estimation of average non-steady-state drug concentration (Cuneq(T)) for irregular dosing intervals.
Area of Science:
- Pharmacokinetics and Pharmacodynamics
- Computational Pharmacology
- Drug Dosing Optimization
Background:
- Complex dosing regimens are common in clinical practice.
- Accurate calculation and optimization of drug dosages are crucial for patient safety and treatment efficacy.
- Existing methods for calculating nonuniform dosing regimens can be time-consuming.
Purpose of the Study:
- To introduce CONSAM, a general dosing program for calculating complex dosing regimens.
- To demonstrate the program's utility in optimizing drug dosages for individual patients.
- To present a novel parameter, Cuneq(T), for characterizing drug concentrations with irregular dosing.
Main Methods:
- Development of a general dosing program (CONSAM) using a universal dosing regimen approach.
- Simulation of complex dosing regimens for linear models with up to n=3 compartments.
- Curve fitting of subject data to obtain individual estimates for dosage optimization.
- Estimation of the new parameter Cuneq(T).
Main Results:
- CONSAM provides a rapid method for calculating nonuniform dosing regimens.
- The program enables individual subject data curve fitting for personalized dosage optimization.
- The study successfully optimized a theophylline regimen using the program.
- A new parameter, Cuneq(T), was estimated for drugs with irregular dosing intervals.
Conclusions:
- CONSAM is an efficient tool for calculating and optimizing complex drug dosing regimens.
- The program's ability to handle individual subject data and irregular dosing intervals enhances its clinical applicability.
- The introduction of Cuneq(T) offers a valuable metric for assessing drug exposure under non-steady-state conditions.